ARCHIVES

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 39 No. 26 | June 26, 2013

Download PDF Visit The Full Archive

Related Articles

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

August 13, 2004

Pharmacogenomics May Lead To Individualized Treatment

June 25, 2004

Hospitals Win Grants For Radiation Oncology Disparity Research.

January 3, 2003

In Brief: Frozen Panels Available to Evaluate diagnostic Assays; Panel to Meet at Johns Hopkins April 22

March 15, 1985

Sequestration: $1.71 Billion Cut to NIH Budget Will Reduce Number of RPGs

May 17, 2013

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997